Free Trial
CVE:VIR

Viridium Pacific Group (VIR) Stock Price, News & Analysis

Viridium Pacific Group logo
C$0.38 +0.02 (+5.56%)
As of 06/7/2019

About Viridium Pacific Group Stock (CVE:VIR)

Key Stats

Today's Range
C$0.37
C$0.41
50-Day Range
C$0.38
C$0.38
52-Week Range
C$0.36
C$1.15
Volume
26,500 shs
Average Volume
92,632 shs
Market Capitalization
C$37.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Receive VIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter.

VIR Stock News Headlines

Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
Pacific American Holdings Acquires Promising Silver Project
Pacific Urban Investors acquires Cupertino apartments
See More Headlines

VIR Stock Analysis - Frequently Asked Questions

Viridium Pacific Group's stock was trading at C$0.38 on January 1st, 2025. Since then, VIR stock has increased by 0.0% and is now trading at C$0.38.
View the best growth stocks for 2025 here
.

Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Allena Pharmaceuticals (ALNA), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:VIR
CIK
N/A
Fax
N/A
Employees
580
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.09 million
Cash Flow
C$0.13 per share
Price / Cash Flow
2.92
Book Value
C$0.29 per share
Price / Book
1.30

Miscellaneous

Free Float
N/A
Market Cap
C$37.52 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (CVE:VIR) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners